Cargando…

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma

PURPOSE: High mobility group box 3 (HMGB3) is associated with hepatocytes malignant transformation by our previous work. We continued to investigate the diagnostic and prognostic values of HMGB3 for hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Circulating HMGB3 levels were quantitatively de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Wenjie, Yang, Junling, Dong, Zhizhen, Wang, Li, Fang, Miao, Wu, Wei, Yao, Dengfu, Yao, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255278/ https://www.ncbi.nlm.nih.gov/pubmed/30538547 http://dx.doi.org/10.2147/CMAR.S181742

Ejemplares similares

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2019)

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
por: Zheng, Wenjie, et al.
Publicado: (2016)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
por: Sai, Wenli, et al.
Publicado: (2015)

Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis
por: Zheng, Wenjie, et al.
Publicado: (2020)

Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Li, Shanshan, et al.
Publicado: (2011)

Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
por: Dong, Zhizhen, et al.
Publicado: (2018)

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
por: Liu, Furong, et al.
Publicado: (2012)

High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis
por: Zhang, Qiang-Bo, et al.
Publicado: (2016)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma
por: Wei, Yong-Guang, et al.
Publicado: (2022)

The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2015)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
por: Piñero, Federico, et al.
Publicado: (2020)

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients
por: Zhu, Weiwei, et al.
Publicado: (2018)

Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2016)

High mobility group box 2 modulates the progression of osteosarcoma and is related with poor prognosis
por: Yang, Shicong, et al.
Publicado: (2020)

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
por: Walker, Lauren Elizabeth, et al.
Publicado: (2017)

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
por: Zhang, Huarong, et al.
Publicado: (2023)

Retraction Note: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2018)

Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma
por: Wu, Dehai, et al.
Publicado: (2018)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
por: Athavale, Dipti, et al.
Publicado: (2022)

High mobility group box-1 levels in schizophrenia: Potential biomarker of remission phase
por: Yilmaz, Nuryil, et al.
Publicado: (2021)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
por: Huang, Changkun, et al.
Publicado: (2018)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis
por: Ren, Chao, et al.
Publicado: (2021)

Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma
por: Cai, Yongchao, et al.
Publicado: (2022)

Starvation insult induces the translocation of high mobility group box 1 to cytosolic compartments in glioma
por: Cui, Xiaohang, et al.
Publicado: (2023)

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis
por: DONG, ZHIZHEN, et al.
Publicado: (2014)

Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes
por: Zhang, Yuan, et al.
Publicado: (2015)

Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI
por: Huang, Junting, et al.
Publicado: (2021)

Identification of Proteins Interacting with Cytoplasmic High-Mobility Group Box 1 during the Hepatocellular Response to Ischemia Reperfusion Injury
por: Zhang, Tianjiao, et al.
Publicado: (2017)

lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Chao, Yanjun, et al.
Publicado: (2019)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmao71lk7tuf16ldtvtg8a09ps